Green Firm Builds Roster of PVCT Cases

The Green Firm has now filed 5 FINRA claims against TD Ameritrade related to its sell "lockout" of customers holding stock in biopharmaceutical company Provectus (symbol: PVCT) for much of the trading day on 1/23/14. We have several times that many cases in development against TD Ameritrade and other brokerages.

If you or someone you know was the victim of a sell "lockout" in your online trading account, please contact us immediately for a free consultation at 1-855-462-3330 or click here to email us.

PA investor lost more than $500,000 in PVCT

The Green Firm has been retained to investigate the more than $500,000 in losses suffered by a professional investor based in Pennsylvania who was unable to sell shares of Provectus Biopharmaceutical stock (PVCT) on January 23, 2104. This investor was prevented from selling PVCT for most of the trading day by his long-time brokerage firm, TD Ameritrade, during a day of extraordinary trading activity (more than 30 million shares) and the stock's crash from above $6 per share to below $2 per share.

PVCT Ameritrade & Fidelity Trading "Lockout"

The Green Firm is currently investigating an alleged trading lockout of TD Ameritrade, Fidelity, Charles Schwab, and Wells Fargo customers who were unable to trade shares of biopharmaceutical company Provectus (symbol: PVCT) on January 23, 2014. For much of the trading day, scores of investors found themselves prevented from selling their shares of PVCT, even as trading in the cancer drug company was heavy and as other investors using brokerages such as E*Trade and USAA had no issues trading. On January 23, 2014, shares of PVCT stock fell from an opening of $5.60 to just $1.87. If you or anyone you know has been the victim of this alleged trading lockout, please contact us or have your attorney contact us at 215 462 3330 or info@greenlegalteam.com.